A Study to Evaluate the Efficacy and Safety of BX-001N in Preventing Cardiac Surgery-Associated Acute Kidney Injury (CSA-AKI) and Major Adverse Kidney Events (MAKE)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Myung Lip Kim, Chief Executive Officer
Bilix Co.,Ltd.
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Keimyung University Dongsan Medical Center
Daegu, South Korea
Yun Seok Kim, MD, PhDNot, yet, recruiting - Seoul National University Bundang Hospital
Seongnam, South Korea
Jae Hang Lee, MD, PhDNot, yet, recruiting - Korea University Anam Hospital
Seoul, South Korea
Hee Jung Kim, MD, PhDRecruiting - Samsung Medical Center
Seoul, South Korea
Su Ryeun Chung, MDNot, yet, recruiting - Seoul Asan Medical Center
Seoul, South Korea
Joon Bum Kim, MD, PhDRecruiting - Seoul National University Hospital
Seoul, South Korea
Jae Woong Choi, MD, PhDRecruiting - Severance Hospital
Seoul, South Korea
Hyun Chel Joo, MD, PhDRecruiting - Pusan National University Yangsan Hospital
Yangsan, South Korea
Chee Hoon Lee, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Aug 2025
- Primary completion
- 30 Sept 2027
- Completion
- 30 Apr 2028
- Last update posted
- 1 Jul 2026
- Registered enrollment
- 50
- Registry id
- NCT07164833
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.